282 related articles for article (PubMed ID: 23077666)
1. Conditional astroglial Rictor overexpression induces malignant glioma in mice.
Bashir T; Cloninger C; Artinian N; Anderson L; Bernath A; Holmes B; Benavides-Serrato A; Sabha N; Nishimura RN; Guha A; Gera J
PLoS One; 2012; 7(10):e47741. PubMed ID: 23077666
[TBL] [Abstract][Full Text] [Related]
2. microRNA-153 Targets mTORC2 Component Rictor to Inhibit Glioma Cells.
Cui Y; Zhao J; Yi L; Jiang Y
PLoS One; 2016; 11(6):e0156915. PubMed ID: 27295037
[TBL] [Abstract][Full Text] [Related]
3. Rictor/mTORC2 pathway in oocytes regulates folliculogenesis, and its inactivation causes premature ovarian failure.
Chen Z; Kang X; Wang L; Dong H; Wang C; Xiong Z; Zhao W; Jia C; Lin J; Zhang W; Yuan W; Zhong M; Du H; Bai X
J Biol Chem; 2015 Mar; 290(10):6387-96. PubMed ID: 25564616
[TBL] [Abstract][Full Text] [Related]
4. Phosphorylation of the Hippo Pathway Component AMOTL2 by the mTORC2 Kinase Promotes YAP Signaling, Resulting in Enhanced Glioblastoma Growth and Invasiveness.
Artinian N; Cloninger C; Holmes B; Benavides-Serrato A; Bashir T; Gera J
J Biol Chem; 2015 Aug; 290(32):19387-401. PubMed ID: 25998128
[TBL] [Abstract][Full Text] [Related]
5. Involvement of Rictor/mTORC2 in cardiomyocyte differentiation of mouse embryonic stem cells
Zheng B; Wang J; Tang L; Tan C; Zhao Z; Xiao Y; Ge R; Zhu D
Int J Biol Sci; 2017; 13(1):110-121. PubMed ID: 28123351
[TBL] [Abstract][Full Text] [Related]
6. mTORC2 activity is elevated in gliomas and promotes growth and cell motility via overexpression of rictor.
Masri J; Bernath A; Martin J; Jo OD; Vartanian R; Funk A; Gera J
Cancer Res; 2007 Dec; 67(24):11712-20. PubMed ID: 18089801
[TBL] [Abstract][Full Text] [Related]
7. Depletion of Rictor, an essential protein component of mTORC2, decreases male lifespan.
Lamming DW; Mihaylova MM; Katajisto P; Baar EL; Yilmaz OH; Hutchins A; Gultekin Y; Gaither R; Sabatini DM
Aging Cell; 2014 Oct; 13(5):911-7. PubMed ID: 25059582
[TBL] [Abstract][Full Text] [Related]
8. mTORC1 and mTORC2 regulate insulin secretion through Akt in INS-1 cells.
Le Bacquer O; Queniat G; Gmyr V; Kerr-Conte J; Lefebvre B; Pattou F
J Endocrinol; 2013 Jan; 216(1):21-9. PubMed ID: 23092880
[TBL] [Abstract][Full Text] [Related]
9. MiR-424/503-mediated Rictor upregulation promotes tumor progression.
Oneyama C; Kito Y; Asai R; Ikeda J; Yoshida T; Okuzaki D; Kokuda R; Kakumoto K; Takayama K; Inoue S; Morii E; Okada M
PLoS One; 2013; 8(11):e80300. PubMed ID: 24244675
[TBL] [Abstract][Full Text] [Related]
10. Rictor/mTORC2 Drives Progression and Therapeutic Resistance of HER2-Amplified Breast Cancers.
Morrison Joly M; Hicks DJ; Jones B; Sanchez V; Estrada MV; Young C; Williams M; Rexer BN; Sarbassov dos D; Muller WJ; Brantley-Sieders D; Cook RS
Cancer Res; 2016 Aug; 76(16):4752-64. PubMed ID: 27197158
[TBL] [Abstract][Full Text] [Related]
11. IKK interacts with rictor and regulates mTORC2.
Xu Y; Lai E; Liu J; Lin J; Yang C; Jia C; Li Y; Bai X; Li M
Cell Signal; 2013 Nov; 25(11):2239-45. PubMed ID: 23872070
[TBL] [Abstract][Full Text] [Related]
12. Transmembrane Inhibitor of RICTOR/mTORC2 in Hematopoietic Progenitors.
Lee D; Sykes SM; Kalaitzidis D; Lane AA; Kfoury Y; Raaijmakers MH; Wang YH; Armstrong SA; Scadden DT
Stem Cell Reports; 2014 Nov; 3(5):832-40. PubMed ID: 25418727
[TBL] [Abstract][Full Text] [Related]
13. Opposing Tumor-Promoting and -Suppressive Functions of Rictor/mTORC2 Signaling in Adult Glioma and Pediatric SHH Medulloblastoma.
Akgül S; Li Y; Zheng S; Kool M; Treisman DM; Li C; Wang Y; Gröbner S; Ikenoue T; Shen Y; Camelo-Piragua S; Tomasek G; Stark S; Guduguntla V; Gusella JF; Guan KL; Pfister SM; Verhaak RGW; Zhu Y
Cell Rep; 2018 Jul; 24(2):463-478.e5. PubMed ID: 29996106
[TBL] [Abstract][Full Text] [Related]
14. mTORC1-activated S6K1 phosphorylates Rictor on threonine 1135 and regulates mTORC2 signaling.
Julien LA; Carriere A; Moreau J; Roux PP
Mol Cell Biol; 2010 Feb; 30(4):908-21. PubMed ID: 19995915
[TBL] [Abstract][Full Text] [Related]
15. Selective disruption of mTORC1 and mTORC2 in VTA astrocytes induces depression and anxiety-like behaviors in mice.
Zheng Z; Zhou H; Yang L; Zhang L; Guo M
Behav Brain Res; 2024 Apr; 463():114888. PubMed ID: 38307148
[TBL] [Abstract][Full Text] [Related]
16. Rictor Undergoes Glycogen Synthase Kinase 3 (GSK3)-dependent, FBXW7-mediated Ubiquitination and Proteasomal Degradation.
Koo J; Wu X; Mao Z; Khuri FR; Sun SY
J Biol Chem; 2015 May; 290(22):14120-9. PubMed ID: 25897075
[TBL] [Abstract][Full Text] [Related]
17. Deletion of Rictor in neural progenitor cells reveals contributions of mTORC2 signaling to tuberous sclerosis complex.
Carson RP; Fu C; Winzenburger P; Ess KC
Hum Mol Genet; 2013 Jan; 22(1):140-52. PubMed ID: 23049074
[TBL] [Abstract][Full Text] [Related]
18. Identification of rictor as a novel substrate of Polo-like kinase 1.
Shao T; Liu X
Cell Cycle; 2015; 14(5):755-60. PubMed ID: 25714006
[TBL] [Abstract][Full Text] [Related]
19. Resveratrol-mediated downregulation of Rictor attenuates autophagic process and suppresses UV-induced skin carcinogenesis.
Back JH; Zhu Y; Calabro A; Queenan C; Kim AS; Arbesman J; Kim AL
Photochem Photobiol; 2012; 88(5):1165-72. PubMed ID: 22272775
[TBL] [Abstract][Full Text] [Related]
20. Targeting of mTORC2 may have advantages over selective targeting of mTORC1 in the treatment of malignant pheochromocytoma.
Zhang X; Wang X; Xu T; Zhong S; Shen Z
Tumour Biol; 2015 Jul; 36(7):5273-81. PubMed ID: 25666752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
